Search Results
MindMed - executive interview with Dan Karlin, CMO
LSD for anxiety and psychedelic clinical trials with MindMed CMO, Dr. Daniel Karlin
MindMed: Executive interview
Investing in Psychedelics a Conversation with MindMed
The MindMed Chronicles | A Conversation With Robert Barrow CEO Of MindMed | Psychedelic Invest
MindMed CEO Explains New Vision For Company - TDR Exclusive
Mindmed CBS | Robert Barrow | Daily Flash
MindMed 's Plan to END the Opioid Epidemic (How MMED / MMEDF Could Make Billions)
Basilea Pharmaceutica – executive interview
MindMed Shifting Mental Health Paradigms & More
intelGenx Receives FDA Approval | MindMed's 18MC On Clinical Hold
Technology In Mental Health: Role Of The Treatment Team
